| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2478216 | Annales Pharmaceutiques Françaises | 2011 | 4 Pages |
Abstract
There are only few observations that have been reported in the literature regarding the efficacity of rituximab in the treatment of cold agglutinin disease. This promising therapy could, in the future, constitute a real alternative.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Y. Sekkach, S. Hammi, M. Elqatni, J. Fatihi, N. Elomri, F. Mekouar, M. Badaoui, M. Jira, J. Smaali, A. El Khattabi, T. Amezyane, A. Abouzahir, D. Ghafir,